Literature DB >> 8345790

Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis.

L Ananth1, P E Prete, M L Kashyap.   

Abstract

Synovial fluid (SF) of patients with rheumatoid arthritis (RA) has been noted to contain cholesterol crystals and increased amounts of cholesterol compared with normal SF. SF, plasma apolipoproteins (apos) A-I and B, and cholesterol in 12 untreated classic RA patients (inflammatory arthritis) and eight untreated degenerative joint disease ([DJD] noninflammatory arthritis) patients were analyzed. Results showed that mean apo A-I, apo B, and cholesterol levels of RA SF were significantly higher than those of DJD SF (apo A-I, P = .004; apo B, P = .0008; cholesterol, P = .0004). Regression analyses of plasma and SF apo A-I and apo B (r = .72, P = .008 and r = .63, P = .02, respectively) suggested an increased permeability for these lipoprotein constituents across RA synovial membrane that was not observed in DJD synovial membrane. These data suggest that RA synovium but not DJD synovium is more permeable to major apoproteins of low- and high-density lipoproteins (LDL and HDL). These apolipoproteins have been shown to influence the immune response and may therefore be involved in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345790     DOI: 10.1016/0026-0495(93)90050-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  A cholesterol-containing foreign body granuloma presenting as an inter-metatarsal bursa.

Authors:  R S D Campbell; R J Montgomery
Journal:  Skeletal Radiol       Date:  2004-07-28       Impact factor: 2.199

Review 2.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; David Meriwether; Yuen Yin Lee; Ani Shahbazian; Srinivasa T Reddy
Journal:  Clin Rheumatol       Date:  2017-11-11       Impact factor: 2.980

Review 4.  [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation].

Authors:  M Rossol; H Häntzschel; U Wagner
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

5.  Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints.

Authors:  N Busso; J Dudler; R Salvi; V Péclat; V Lenain; S Marcovina; R Darioli; P Nicod; A K So; V Mooser
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

7.  Disease-specific proteins from rheumatoid arthritis patients.

Authors:  Choong Won Kim; Eun Hye Cho; Yun Jong Lee; Yoon Hee Kim; Young Sool Hah; Deok Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

Review 8.  Lipid and Metabolic Changes in Rheumatoid Arthritis.

Authors:  Catherine M McGrath; Stephen P Young
Journal:  Curr Rheumatol Rep       Date:  2015-09       Impact factor: 4.592

Review 9.  The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction.

Authors:  Danielle Burger; Jean-Michel Dayer
Journal:  Arthritis Res       Date:  2002-05-09

10.  Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?

Authors:  Barry Bresnihan; Martina Gogarty; Oliver FitzGerald; Jean-Michel Dayer; Danielle Burger
Journal:  Arthritis Res Ther       Date:  2004       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.